1.
Dubey D, Pittock SJ, Kelly CR, McKeon A, Lopez-Chiriboga AS, Lennon VA, et al. Autoimmune
encephalitis epidemiology and a comparison to infectious encephalitis. Ann Neurol.
2018;83(1):166-77.
2.
Dalmau J, Tuzun E, Wu HY, Masjuan J, Rossi JE, Voloschin A, et al. Paraneoplastic
anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma.
Ann Neurol. 2007;61(1):25-36.
3.
Saraya A, Mahavihakanont A, Shuangshoti S, Sittidetboripat N, Deesudchit T, Callahan
M, et al. Autoimmune causes of encephalitis syndrome in Thailand: prospective study
of 103 patients. BMC Neurol. 2013;13:150.
4.
Gable MS, Gavali S, Radner A, Tilley DH, Lee B, Dyner L, et al. Anti-NMDA receptor
encephalitis: report of ten cases and comparison with viral encephalitis. Eur J Clin
Microbiol Infect Dis. 2009;28(12):1421-9.
5.
MBBS SA, Lim S-Y, Goh KJ, Lum LC, Tan CT. Anti-N-methyl-D-aspartate receptor (NMDAR)
encephalitis: A series of ten cases from a university hospital in Malaysia. Neurology
Asia. 2011;16(3):241-6.
6.
Kaneko J, Kanazawa N, Tominaga N, Kaneko A, Suga H, Usui R, et al. Practical issues
in measuring autoantibodies to neuronal cell-surface antigens in autoimmune neurological
disorders: 190 cases. J Neurol Sci. 2018;390:26-32.
7.
Kamble N, Netravathi M, Saini J, Mahadevan A, Yadav R, Nalini A, et al. Clinical and
imaging characteristics of 16 patients with autoimmune neuronal synaptic encephalitis.
Neurol India. 2015;63(5):687-96.
8.
Dale RC, Merheb V, Pillai S, Wang D, Cantrill L, Murphy TK, et al. Antibodies to surface
dopamine-2 receptor in autoimmune movement and psychiatric disorders. Brain. 2012;135(Pt
11):3453-68.
9.
Piepgras J, Holtje M, Michel K, Li Q, Otto C, Drenckhahn C, et al. Anti-DPPX encephalitis:
pathogenic effects of antibodies on gut and brain neurons. Neurology. 2015;85(10):890-7.
10.
Gaig C, Graus F, Compta Y, Hogl B, Bataller L, Bruggemann N, et al. Clinical manifestations
of the anti-IgLON5 disease. Neurology. 2017;88(18):1736-43.
11.
Gresa-Arribas N, Planaguma J, Petit-Pedrol M, Kawachi I, Katada S, Glaser CA, et al.
Human neurexin-3alpha antibodies associate with encephalitis and alter synapse development.
Neurology. 2016;86(24):2235-42.
12.
Irani SR, Alexander S, Waters P, Kleopa KA, Pettingill P, Zuliani L, et al. Antibodies
to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein
and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired
neuromyotonia. Brain. 2010;133(9):2734-48.
13.
Lancaster E, Lai M, Peng X, Hughes E, Constantinescu R, Raizer J, et al. Antibodies
to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation
of the antigen. Lancet Neurol. 2010;9(1):67-76.
14.
Ohkawa T, Satake S, Yokoi N, Miyazaki Y, Ohshita T, Sobue G, et al. Identification
and characterization of GABA(A) receptor autoantibodies in autoimmune encephalitis.
J Neurosci. 2014;34(24):8151-63.
15.
Petit-Pedrol M, Armangue T, Peng X, Bataller L, Cellucci T, Davis R, et al. Encephalitis
with refractory seizures, status epilepticus, and antibodies to the GABAA receptor:
a case series, characterisation of the antigen, and analysis of the effects of antibodies.
Lancet Neurol. 2014;13(3):276-86.
16.
Dalmau J, Graus F. Antibody-Mediated Encephalitis. N Engl J Med. 2018;378(9):840-51.
17.
Dalmau J, Geis C, Graus F. Autoantibodies to Synaptic Receptors and Neuronal Cell
Surface Proteins in Autoimmune Diseases of the Central Nervous System. Physiol Rev.
2017;97(2):839-87.
18.
Planaguma J, Leypoldt F, Mannara F, Gutierrez-Cuesta J, Martin-Garcia E, Aguilar E,
et al. Human N-methyl D-aspartate receptor antibodies alter memory and behaviour in
mice. Brain. 2015;138(Pt 1):94-109.
19.
Lancaster E. Paraneoplastic Disorders. Continuum (Minneap Minn). 2017;23(6, Neuro-oncology):1653-79.
20.
Zhang L, Qian W, Chen Q, Yin L, Li B, Wang H. Imbalance in circulating T lymphocyte
subsets contributes to Hu antibody-associated paraneoplastic neurological syndromes.
Cell Immunol. 2014;290(2):245-50.
21.
van Coevorden-Hameete MH, Titulaer MJ, Schreurs MW, de Graaff E, Sillevis Smitt PA,
Hoogenraad CC. Detection and Characterization of Autoantibodies to Neuronal Cell-Surface
Antigens in the Central Nervous System. Frontiers in molecular neuroscience. 2016;9:37.
22.
Steiner I, Budka H, Chaudhuri A, Koskiniemi M, Sainio K, Salonen O, et al. Viral meningoencephalitis:
a review of diagnostic methods and guidelines for management. Eur J Neurol. 2010;17(8):999-e57.
23.
Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T, et al. A clinical approach
to diagnosis of autoimmune encephalitis. Lancet Neurol. 2016;15(4):391-404.
24.
Hanly JG. Diagnosis and management of neuropsychiatric SLE. Nat Rev Rheumatol. 2014;10(6):338-47.
25.
Al-Diwani A, Handel A, Townsend L, Pollak T, Leite MI, Harrison PJ, et al. The psychopathology
of NMDAR-antibody encephalitis in adults: a systematic review and phenotypic analysis
of individual patient data. Lancet Psychiatry. 2019;6(3):235-46.
26.
Wang W, Li JM, Hu FY, Wang R, Hong Z, He L, et al. Anti-NMDA receptor encephalitis:
clinical characteristics, predictors of outcome and the knowledge gap in southwest
China. Eur J Neurol. 2016;23(3):621-9.
27.
Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R. Clinical
experience and laboratory investigations in patients with anti-NMDAR encephalitis.
Lancet Neurol. 2011;10(1):63-74.
28.
van Sonderen A, Petit-Pedrol M, Dalmau J, Titulaer MJ. The value of LGI1, Caspr2 and
voltage-gated potassium channel antibodies in encephalitis. Nature reviews Neurology.
2017;13(5):290-301.
29.
Escudero D, Guasp M, Arino H, Gaig C, Martinez-Hernandez E, Dalmau J, et al. Antibody-associated
CNS syndromes without signs of inflammation in the elderly. Neurology. 2017;89(14):1471-5.
30.
Celicanin M, Blaabjerg M, Maersk-Moller C, Beniczky S, Marner L, Thomsen C, et al.
Autoimmune encephalitis associated with voltage-gated potassium channels-complex and
leucine-rich glioma-inactivated 1 antibodies - a national cohort study. Eur J Neurol.
2017;24(8):999-1005.
31.
Thompson J, Bi M, Murchison AG, Makuch M, Bien CG, Chu K, et al. The importance of
early immunotherapy in patients with faciobrachial dystonic seizures. Brain. 2018;141(2):348-56.
32.
Gadoth A, Pittock SJ, Dubey D, McKeon A, Britton JW, Schmeling JE, et al. Expanded
phenotypes and outcomes among 256 LGI1/CASPR2-IgG-positive patients. Ann Neurol. 2017;82(1):79-92.
33.
Dogan Onugoren M, Deuretzbacher D, Haensch CA, Hagedorn HJ, Halve S, Isenmann S, et
al. Limbic encephalitis due to GABAB and AMPA receptor antibodies: a case series.
J Neurol Neurosurg Psychiatry. 2015;86(9):965-72.
34.
Leypoldt F, Armangue T, Dalmau J. Autoimmune encephalopathies. Ann N Y Acad Sci. 2015;1338:94-114.
35.
Vitaliani R, Mason W, Ances B, Zwerdling T, Jiang Z, Dalmau J. Paraneoplastic encephalitis,
psychiatric symptoms, and hypoventilation in ovarian teratoma. Ann Neurol. 2005;58(4):594-604.
36.
Dalmau J, Gleichman AJ, Hughes EG, Rossi JE, Peng X, Lai M, et al. Anti-NMDA-receptor
encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol.
2008;7(12):1091-8.
37.
Day GS, Laiq S, Tang-Wai DF, Munoz DG. Abnormal neurons in teratomas in NMDAR encephalitis.
JAMA Neurol. 2014;71(6):717-24.
38.
Titulaer MJ, McCracken L, Gabilondo I, Armangue T, Glaser C, Iizuka T, et al. Treatment
and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis:
an observational cohort study. Lancet Neurol. 2013.
39.
Lim JA, Lee ST, Jung KH, Kim S, Shin JW, Moon J, et al. Anti-N-methyl-d-aspartate
receptor encephalitis in Korea: clinical features, treatment, and outcome. J Clin
Neurol. 2014;10(2):157-61.
40.
Graus F, Delattre JY, Antoine JC, Dalmau J, Giometto B, Grisold W, et al. Recommended
diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg
Psychiatry. 2004;75(8):1135-40.
41.
Florance NR, Davis RL, Lam C, Szperka C, Zhou L, Ahmad S, et al. Anti-N-methyl-D-aspartate
receptor (NMDAR) encephalitis in children and adolescents. Ann Neurol. 2009;66(1):11-8.
42.
Varley JA, Webb AJS, Balint B, Fung VSC, Sethi KD, Tijssen MAJ, et al. The Movement
disorder associated with NMDAR antibody-encephalitis is complex and characteristic:
an expert video-rating study. J Neurol Neurosurg Psychiatry. 2018.
43.
Shiraga S, Adamus G. Mechanism of CAR syndrome: anti-recoverin antibodies are the
inducers of retinal cell apoptotic death via the caspase 9- and caspase 3-dependent
pathway. J Neuroimmunol. 2002;132(1-2):72-82.
44.
Stich O, Klages E, Bischler P, Jarius S, Rasiah C, Voltz R, et al. SOX1 antibodies
in sera from patients with paraneoplastic neurological syndromes. Acta neurologica
Scandinavica. 2012;125(5):326-31.
45.
Berger B, Stich O, Labeit S, Rauer S. Screening for anti-titin antibodies in patients
with various paraneoplastic neurological syndromes. J Neuroimmunol. 2016;295-296:18-20.